Results 191 to 200 of about 213,613 (314)

Post‐Translational Modified Neoantigens in Autoimmune Diseases: Challenges of Immune Tolerance

Advanced Science, EarlyView.
Autoimmune diseases have a high incidence and disability rate. The pathogenesis of autoimmune diseases involves the interaction among genetic factors, environmental factors, and immune disorders. The post‐translational modified neoantigens are the key nodal of these three factors. And these post‐translational modified neoantigens, after being presented
Yue Zhai, Kefei Wu, Qi Lin, Zhenzhen Cao, Yankun Jia, Ping Zhu   +5 more
wiley   +1 more source

Exploring the predictive power of antinuclear antibodies and Rheumatoid factor correlations in anticipating therapeutic outcomes for female patients with coexisting Sjögren's syndrome and Rheumatoid arthritis. [PDF]

J Oral Biol Craniofac Res
Krishnan Pandarathodiyil A, Shree K H, Ramani P, Sivapathasundharam B, Ramadoss R.   +4 more
europepmc   +1 more source

Inhibition by Rheumatoid Factor, Anti-Fc, and Staphylococcal Protein A of Antibody-Dependent Cell-Mediated Cytolysis against Herpes Simplex Virus-Infected Cells [PDF]

, 1976
R. Marshall Austin, Charles A. Daniels
openalex   +1 more source

Dopamine D1 Receptor Contributes to Glucocorticoid‐Associated Osteonecrosis of Femoral Head Protection Through the ATF3/CHOP Axis to Inhibit Osteoblastic Apoptosis

Advanced Science, EarlyView.
This work identifies a novel mechanism by which dopamine D1 receptor (DRD1) contributes to the pathogenesis of glucocorticoid (GC)‐associated osteonecrosis of the femoral head (ONFH) through the regulation of osteoblastic apoptosis, indicating that DRD1 serves as a critical mediator of the crosstalk between the nervous and skeletal systems.
Kai Zheng, Wenming Li, Tianhao Wang, Gaoran Ge, Wei Zhang, Yi Qin, Wenhao Li, Zebin Wu, Zhen Wang, Gang Rui, Yaozeng Xu, Dechun Geng   +11 more
wiley   +1 more source

Clinical and laboratory pattern of patients with systemic lupus erythematosus seropositive for rheumatoid factor. [PDF]

Reumatologia
Iaremenko O, Protsenko G, Dubas V, Koliadenko D.   +3 more
europepmc   +1 more source

Retracted: Comprehensive Medical Analysis of Clinical Diseases and Syndromes Based on Rheumatoid Factor Interfering Immune Blood Cell Damage. [PDF]

J Healthc Eng, 2023
Engineering JOH.
europepmc   +1 more source

STUDIES ON RHEUMATOID FACTOR

, 1963
Shoichiro Irimajiri
openalex   +2 more sources

Gasdermin D‐Mediated Pyroptosis Exerts Two Opposite Effects of Resisting Enzymatic Digestion and Expanding Inflammatory Response in Acute Pancreatitis

Advanced Science, EarlyView.
Gasdermin D (GSDMD) does not only reduce pancreatic enzyme synthesis but also induces pancreatic acinar cells to express mucin 1 (MUC1), which forms a barrier to prevent digestive enzyme‐mediated digestion. However, GSDMD can promote the secretion of inflammatory cytokines by macrophages and aggravate pancreatic histological injury by expanding ...
Chaoxu Liu, Ning Liang, Chen Wu, Zhaoyan Qiu, Qian Huang, Xiaolong Wei, Shurong Zhang, Shuanghong Lei, Tao Yang, Gang Wang, Qian Wang   +10 more
wiley   +1 more source

Nationwide study on the prevalence of rheumatoid factor and anticitrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis. [PDF]

Turk J Med Sci
Satiş H, Erden A, Bilgin E, Ayan G, Armağan B, Tecer D, Sari A, Kalyoncu U, Çağlayan M, Ülgü MM, Ayvali MO, Ata N, Birinci Ş.   +12 more
europepmc   +1 more source

Anti-drug antibodies and rheumatoid factor level in patients with rheumatoid arthritis using the infliximab biosimilar CT-P13. [PDF]

BMC Rheumatol, 2022
Sakane H, Okamura K, Inoue M, Inoue H, Yonemoto Y, Mitomi H, Tsuchida K, Suto T, Kaneko T, Chikuda H.   +9 more
europepmc   +1 more source